Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
fluorescein (2 trials)
Fatty Liver (Phase 2)
Fibrosis (Phase 2)
Liver Cirrhosis (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Trials (2 total)
Trial APIs (1 total)